Director Kelly Gold granted 110,000 X4 Pharmaceuticals (XFOR) stock options at $4.085
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
X4 Pharmaceuticals director Kelly Gold received a stock option grant as part of compensation. The award covers 110,000 shares of common stock with an exercise price of $4.085 per share and expires on July 1, 2036. According to the disclosure, these options were granted at no cost on the grant date and will vest in full on the one-year anniversary of the grant date, as long as Gold continues providing services through that date. Following this award, Gold is reported to hold stock options covering 110,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Gold Kelly
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 110,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 110,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option shares granted: 110,000 shares
Exercise price: $4.085 per share
Post-grant option holdings: 110,000 shares
+2 more
5 metrics
Option shares granted
110,000 shares
Stock option award to director on grant date
Exercise price
$4.085 per share
Strike price of newly granted options
Post-grant option holdings
110,000 shares
Total option shares held following transaction
Option expiration date
July 1, 2036
Expiration of the stock option grant
Vesting schedule
100% after one year
Vests on one-year anniversary of grant if services continue
Key Terms
Stock Option (right to buy), exercise price, vest in full, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price": "4.0850""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in full financial
"The shares subject to the option shall vest in full on the one-year anniversary"
expiration date financial
"expiration_date": "2036-07-01T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
derivative securities financial
"transaction_type": "derivative""
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What did XFOR director Kelly Gold report in this Form 4 filing?
Kelly Gold reported receiving a stock option grant for 110,000 XFOR shares. The options were awarded as compensation, giving the right to buy common stock at a preset exercise price if vesting conditions are met.
What is the exercise price of Kelly Gold’s X4 Pharmaceuticals stock options?
The exercise price of the stock options is $4.085 per share. This means Gold can buy up to 110,000 XFOR shares at $4.085 each once the options vest and before they expire, regardless of future market price.
When do Kelly Gold’s XFOR stock options vest and expire?
The options vest in full on the one-year anniversary of the grant date. Vesting requires Gold to continue providing services through that date, and the options expire on July 1, 2036 if not exercised earlier.